Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Nature Neuroscience|November 10, 2009
Dynamic DNA methylation programs persistent adverse effects of early-life stressChris Murgatroyd, Alexandre V Patchev, Yonghe Wu, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 28, 2021
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in miceValentina Chiodi, Maria Rosaria Domenici, Tommaso Biagini, et al.
Frontiers in Pharmacology|April 2, 2014
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanismsPetra Amchova, Jana Kucerova, Valentina Giugliano, et al.
Pharmacological Research|May 28, 2014
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axisAndrea Navarria, Alessandra Tamburella, Fabio A Iannotti, et al.
Diabetes|February 23, 2023
Topically Administered NOX4 Inhibitor, GLX7013114, Is Efficacious in Treating the Early Pathological Events of Diabetic RetinopathyStavroula Dionysopoulou, Per Wikstrom, Claudio Bucolo, et al.
Nature Communications|August 30, 2012
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse modelStephan Direnberger, Marsilius Mues, Vincenzo Micale, et al.
Biomolecules|January 21, 2022
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of SchizophreniaTibor Stark, Fabio Arturo Iannotti, Serena Di Martino, et al.
Schizophrenia Research|January 22, 2017
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophreniaClaudio D'Addario, Vincenzo Micale, Martina Di Bartolomeo, et al.
Pharmacological Research|April 7, 2024
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptorsAntonia Manduca, Valeria Buzzelli, Alessandro Rava, et al.
European Journal of Pharmacology|February 1, 2025
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicityFederica Conti, Francesca Lazzara, Kyriaki Thermos, et al.
Pageof 7